Drug Profile
Taplitumomab paptox
Alternative Names: B43 (anti-CD19) immunotoxin; B43-PAP; Monoclonal antibody B43-PAP conjugateLatest Information Update: 29 Aug 2002
Price :
$50
*
At a glance
- Originator University of Minnesota
- Class Antineoplastics; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Leukaemia